Relievant Medsystems

Relievant Medsystems is a medical device company that developed the Intracept Procedure, a minimally invasive treatment that uses radiofrequency ablation of the basivertebral nerve to relieve chronic vertebrogenic low back pain. Originally venture-backed (including by Canaan Partners), Relievant was acquired by Boston Scientific in 2023, and the Intracept system is now marketed under the Boston Scientific portfolio. The company is a clinical medical-device business focused on physicians, hospitals, and patients rather than a software or API platform, and it publishes no public developer API, SDK, or technical integration surface.

Relievant Medsystems is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Medtech, and Pain Management.

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyMedical DevicesHealthcareMedtechPain ManagementSpineNeuromodulation

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/relievant-medsystems: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Relievant Medsystems Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: relievant-medsystems
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/relievant-medsystems.png
name: Relievant Medsystems
description: Relievant Medsystems is a medical device company that developed the Intracept Procedure, a minimally invasive
  treatment that uses radiofrequency ablation of the basivertebral nerve to relieve chronic vertebrogenic low back pain. Originally
  venture-backed (including by Canaan Partners), Relievant was acquired by Boston Scientific in 2023, and the Intracept system
  is now marketed under the Boston Scientific portfolio. The company is a clinical medical-device business focused on physicians,
  hospitals, and patients rather than a software or API platform, and it publishes no public developer API, SDK, or technical
  integration surface.
url: https://raw.githubusercontent.com/api-evangelist/relievant-medsystems/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-acquired-by: boston-scientific
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Medical Devices
- Healthcare
- Medtech
- Pain Management
- Spine
- Neuromodulation
apis: []
common:
- type: DomainSecurity
  url: security/relievant-medsystems-domain-security.yml
- type: Website
  url: https://www.relievant.com
- type: Website
  name: Intracept Procedure
  url: https://www.intracept.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1